Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Psyched Wellness Stock News

PSYCFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0180

0.0019512.21%

At close: -

$0.0400

0.02122.79%

After Hours: Dec 27, 8:47 AM EDT

Psyched Wellness (PSYCF) Forecast

News

Earnings Psyched Wellness (PSYCF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Psyched Wellness Stock News | OTC:PSYCF | Benzinga

Get the latest news on Psyched Wellness stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Psyched Wellness performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, September 05, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein

Friday, September 01, 2023

EXCLUSIVE: Psychedelics Co. To Get Up To $7.5M In Financing - Here's Its Secret To Raising Millions In A Tough Environment
Javier Hasse

Monday, May 15, 2023

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein

Thursday, May 04, 2023

Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up
Lara Goldstein

Thursday, February 16, 2023

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
Lara Goldstein

Tuesday, January 24, 2023

Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
Lara Goldstein

Thursday, November 03, 2022

Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States
Lara Goldstein

Thursday, October 06, 2022

This Legal Psychoactive Mushroom Reduces Stress And Pain And Encourages Longevity, Expert Says
Natan Ponieman

Wednesday, June 15, 2022

Amanita Muscaria Mushroom-Based Products Now Offered Online By Psyched Wellness
Lara Goldstein

Monday, April 25, 2022

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Natan Ponieman
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
Natan Ponieman

Tuesday, April 19, 2022

EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Dustin Blitchok
Psyched Wellness CEO Buys This Many Shares In The Open Market
Fermin Orgambide

Wednesday, April 06, 2022

Core One Labs Begins Trading On OTCQB
Fermin Orgambide

Monday, October 18, 2021

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman

Wednesday, October 13, 2021

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman

Wednesday, January 27, 2021

First Psychedelics ETF Debuts On NEO Exchange
Natan Ponieman

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved